Biochip Scanner Market By Type (DNA Chips, Lab-On-A-Chip, Protein Chips, Cancer Diagnosis and Treatment, Gene Expression, Single Nucleotide Polymorphism (SNP) Genotyping, Genomics, Drug Discovery, Others) By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes)- Growth, Share, Opportunities & Competitive Analysis, 2016 - 2028

About this report

The global biochip scanner market report explores the critical analysis of the biochip scanner industry using key parameters. The report consists of investment strategies, the need for investments in the biochip scanner industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the biochip scanner industry, as well as how economic and non-economic barriers are helping the biochip scanner market grow. Moreover, the report analyzes the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter's five forces analysis, PESTEL analysis, value chain analysis, etc.

Key Highlights of the report

How are the major segments performing in the Biochip Scanner Market?

In 2021, the DNA Chip will be the leading segment in the type. Their application in diverse fields, including drug discovery, gene expression, genomic studies, cancer treatment, and diagnosis, makes them a highly valuable tool.

In 2021, the hospitals & diagnostics centers category led the biochip scanner industry as a whole, and this trend is anticipated to remain for the entire projection period as it is rapidly becoming the norm for hospitals and diagnostic centers to use biochips for patient monitoring and diagnosis.

Which region dominated the Biochip Scanner Market?

In 2021, North America was one of the major contributors to the global biochip scanner market. As a result of increasing government initiatives to promote R&D through tax credits, this growth can be attributed. In addition to the presence of biotechnology companies, the country has academic and research institutions that contribute to further technological advancements in the application of biochips. For research activities aimed at improving products, formulas, processes, or software, the R&D tax credit offers companies dollar-for-dollar cash savings through federal tax credits.

What is the competitive environment of the Biochip Scanner Market?

The biochip scanner industry's competitive environment offers information on the total economic profit made by suppliers and businesses, the sales and revenues produced in this sector, the biochip scanner market share globally, the business organization overview, the introduction of new technologies, and the opportunities for the biochip scanner market. New technologies are being introduced into the market due to the growing adoption of biochips for cancer treatment. For example, Changwei System Technology Co., Ltd developed In-Vitro Diagnostic Devices (IVDs) and Cancer Differentiation Technology (CDA) in March 2022.

Executive Summary

What are all technical developments being developed in the Biochip Scanner Industry Market?

In recent years, nanotechnology has advanced the capability and reduced the size of biochips, making them more useful in diagnostics, research, drug development, and toxicology studies. Consequently, biochips have been widely adopted in a variety of applications as a result. As a result of the wide use of these chips in genomics, proteomics, personalized medicine, and other applications, existing manufacturers and new startups develop, invest, and introduce new technology. Dutch startup Qurin Diagnostics, for example, is developing cancer detection and treatment using biochips. Their nanotechnology-based platform uses nanotechnology to monitor, diagnose, and treat cancer.

Which are the key investments by the players in the Biochip Scanner Industry Market?

Biochips analyze hundreds of biological reactions quickly. These chips can also trace people or animals and effectively store medical and demographic data. As a result of these multi-functionalities, various investments are made among the key player. For instance, US startup Nutcracker Therapeutics raised USD 167 million to develop mRNA biochips-based manufacturing platforms on 14 March 2022. Biochips were developed by the Technical University of Vienna, a major university in Austria, in May 2021 so that tissue beads could be produced in the desired size and injected with drugs or nutrients.

Some of the major players in the market are

Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, Cepheid Inc, Fluidigm Corporation, GE Healthcare, Hoffman-La-Roche Ltd, Illumina, Inc, Ocimum Biosolutions Ltd, PerkinElmer, Inc, Takara Bio Inc, Thermo Fisher Scientific Inc, Merck Millipore, Sigma-Aldrich Corporation, and Abbott Laboratories.

What are the Major Driving Factors for the Biochip Scanner Market?

Several factors are expected to drive market revenue growth, such as increasing applications of biochips in proteomics, genomics, and drug discovery and high investment in research & development (R&D). Furthermore, biochips are becoming increasingly popular for personalized medicine, and biochips for allergy detection are becoming more common. Moreover, an increase in biochip use in animal medical testing is expected to support revenue growth in this market and the prevalence of life-threatening diseases. Several key factors are driving the growth of the global biochips market, including the increasing use of biochips for cancer treatment, drug discovery, and life science research. By 2030, 21.7 million new cancer cases are expected, and 13 million deaths will occur, according to the American Cancer Society.

What are the Major Risks for the Biochip Scanner Market?

The high cost of making biochips will likely hamper the growth of this market. Microfluidic devices are made primarily from ultraviolet lithography, an expensive and highly complex process requiring highly skilled operators and specialized instruments. Manufacturers are restricted in entering the market and offering a range of alternatives for customers due to the high cost. Biochips are also constrained by a lack of awareness in the emerging market about their use.

Which is the key Type in the Biochip Scanner Market

The DNA biochip scanner sector dominated the biochip scanner market in 2021. It is anticipated that biochips will increase due to the high spending on genomic research and next-generation sequencing and the growing demand for genetic disorders detection and diagnosis. Protein microarrays are anticipated to drive the demand for biochips and a growing number of tissue- and cell-based biochips. In the forecast period, the market is expected to grow due to the adoption of DNA chips to profile gene expression levels in cells, identify novel drugs, determine dissimilarities in gene expression levels, and detect gene mutations. The market is also expected to grow as global genomics expenditures, next-generation sequencing, and a growing number of genetic disorders are detected and diagnosed.

How is the Biochip Scanner Market performing in regions?

In 2021, the global biochip scanner market was dominated by North America. This growth is likely due to the increasing government initiatives that encourage R&D through tax credits. There is a high concentration of biotechnology companies in the country, as well as research and academic institutions, which has led to further advancements in the applications of biochips. Due to the presence of a large number of research and academic laboratories and the increasing adoption of biochip scanners in various applications, the US and Canada are dominating the market. There is an increase in the adoption of biochip scanners in research laboratories and the use of biochip scanning technology in drug development, clinical trials, toxicology studies, diagnostics, and clinical trials across the NA region.

Besides, the biochip scanner market in Asia is anticipated to grow fastest. The Asia-Pacific's key growth factors are a large patient pool, improved access to technology, and improvements in healthcare infrastructure, with India and China leading the way. In order to improve drug discovery and accelerate the development of precision medicines, China is heavily investing in scientific research. As the big players seek to reduce production costs by outsourcing biochips technology to emerging markets, this sector also has a strong growth factor.

What is the regulatory landscape for the Biochip Scanner Market?

The regulatory landscape for this market is that governments are exploring a stricter regulatory approach across regions. Individual freedom is impeded by chips inside the body, where infections are possible. An American regulation has recently decided to ban the forced use of biochips. Privacy concerns and the possibility of biohacking are factors expected to restrain revenue growth.

What is the Market Size of the Biochip Scanner regarding value?

The global biochip scanner market is anticipated to grow at a substantialCAGR of 11.20%in the upcoming years. The global biochip scanner industry was estimated to be worthUSD 13,184.2 million in 2021 and was expected to be worth USD 24,927.7 million by 2028.

What are the major players planning for the future of the Biochip Scanner Market?

It is anticipated that biochips will be integrated with a variety of applications, boosting the market in the future. Additionally, the future scenarios indicate that well-known market players would make major investments in startups. Among the startups raised through series C funding is Nutcracker, a U.S. startup that manufactures RNA via biochips. A comprehensive automated and isolated manufacturing process will be made possible with biochips and nanoparticle delivery technology.

Segmentation of Global Biochip Scanner Market-

Global Biochip Scanner Market – By Type

  • DNA Chips
  • Lab-On-A-Chip
  • Protein Chips
  •  Cancer Diagnosis and Treatment
  •  Gene Expression
  •  Single Nucleotide Polymorphism (SNP) Genotyping
  •  Genomics
  •  Drug Discovery
  •  Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening)

Global Biochip Scanner Market – By End User

  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes

Global Biochip Scanner Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

 Frequently asked questions :

The market for biochip scanner is expected to reach USD 24,927.7 mn by 2028.

The biochip scanner market is expected to see significant CAGR growth over the coming years, at 11.20%.

The report is forecasted from 2016-2028.

The base year of this report is 2015.

Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, epheid Inc, Fluidigm Corporation, GE Healthcare are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Sep 2022
Category:  Medical Devices
Report ID:   60674
Report Format:   PDF
Pages:   120
Rating:    4.1 (45)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support